Table 1.
PRI (P-VASP) | ||||
---|---|---|---|---|
Day 0 | Day 8 | |||
r-value | p-value | r-value | p-value | |
LTA (% inhibition) | ||||
Amplitude | −0.46 | 0.30 | −0.089 | 0.90 |
Slope | −0.11 | 0.83 | −0.40 | 0.40 |
AUC | −0.19 | 0.66 | −0.089 | 0.90 |
PRI (P-VASP) | ||||
---|---|---|---|---|
Day 0 | Day 8 | |||
r-value | p-value | r-value | p-value | |
LTA (% inhibition) | ||||
Amplitude | −0.46 | 0.30 | −0.089 | 0.90 |
Slope | −0.11 | 0.83 | −0.40 | 0.40 |
AUC | −0.19 | 0.66 | −0.089 | 0.90 |